The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity

Area of Science:

• Virology
• Molecular Biology
• Oncology

Background:

• Simian virus 40 (SV40) is a monkey virus linked to human cancers.
• Truncated large tumor antigen (LT) expression, caused by APOBEC-induced mutations, is implicated in Merkel cell polyomavirus-induced carcinoma.
• Activation-induced cytidine deaminase (AID) initiates somatic hypermutation and its dysregulation can lead to lymphomagenesis.

Purpose of the Study:

• To investigate if AID can induce mutations in SV40 LT.
• To explore the role of the SV40 enhancer in targeting somatic hypermutation.
• To understand the potential link between SV40, AID, and tumorigenesis.

Main Methods:

• Assessing somatic hypermutation targeting activity of the SV40 enhancer in various cell types.
• Analyzing AID-induced mutations in SV40 LT within B cells and kidney cells.
• Evaluating the impact of these mutations on LT expression, particularly truncation.

Main Results:

• The SV40 enhancer exhibits significant somatic hypermutation targeting activity across multiple cell types.
• AID-induced mutations were observed to accumulate in SV40 LT in both B cells and kidney cells.
• These mutations resulted in the expression of truncated LT in B cells.

Conclusions:

• The SV40 enhancer's ability to target somatic hypermutation to LT is a potential mechanism for LT truncation.
• This novel mutagenic pathway may contribute to SV40-associated tumorigenesis in various cell types.
• The findings link SV40 infection to malignant development through AID-mediated mutagenesis.